Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Study Finds Rise in Major Depressive Episodes, but Not Treatment, in Older Adults
10/19/2022
Jolynn Tumolo
The estimated prevalence of a major depressive episode among older US adults increased 60% between 2010-2011 and 2018-2019, according to a study published in the Journal of Affective Disorders.
The estimated prevalence of a major depressive episode among older US adults increased 60% between 2010-2011 and 2018-2019, according to a study published in the Journal of Affective Disorders.
The estimated prevalence of a...
10/19/2022
Psych Congress Network
News
Stigma Undermines Care for Patients With Borderline Personality Disorder
10/18/2022
Jolynn Tumolo
People with borderline personality disorder and their carers/families face structural problems in health care, including stigma and limited public health services, according to findings published in the International Journal of Mental Health...
People with borderline personality disorder and their carers/families face structural problems in health care, including stigma and limited public health services, according to findings published in the International Journal of Mental Health...
People with borderline...
10/18/2022
Psych Congress Network
News
Adding Dopamine Antagonist to PPI Therapy for GERD
10/18/2022
Jolynn Tumolo
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line...
10/18/2022
Pharmacy Learning Network
News
Treatment-Resistant Schizophrenia Linked With Increased Depression Severity
10/18/2022
Jolynn Tumolo
“These results show that depressive symptoms are part of the clinical picture of the schizophrenic process, especially in the presence of resistance to treatment," researchers said.
“These results show that depressive symptoms are part of the clinical picture of the schizophrenic process, especially in the presence of resistance to treatment," researchers said.
“These results show that...
10/18/2022
Veterans Health Today
News
Resource Burden Grows With Progression to Intermediate Parkinson Disease
10/17/2022
Jolynn Tumolo
Researchers compared the clinical and economic burden of patients with intermediate-stage Parkinson disease vs those in early stages of the disease.
Researchers compared the clinical and economic burden of patients with intermediate-stage Parkinson disease vs those in early stages of the disease.
Researchers compared the...
10/17/2022
Annals of Long-Term Care
News
Earlier Treatment May Improve Outcomes in Patients With Nonradiographic Axial Spondyloarthritis
10/14/2022
Jolynn Tumolo
Study authors compared early vs late symptom duration and the efficacy of secukinumab in younger vs older patients with nonradiographic axial spondyloarthritis.
Study authors compared early vs late symptom duration and the efficacy of secukinumab in younger vs older patients with nonradiographic axial spondyloarthritis.
Study authors compared early vs...
10/14/2022
First Report Managed Care
News
Antifibrinolytic Injection Recalled
10/14/2022
Jolynn Tumolo
AuroMedics Pharma is voluntarily recalling a prescription antifibrinolytic due to the presence of a piece of metal in a vial.
AuroMedics Pharma is voluntarily recalling a prescription antifibrinolytic due to the presence of a piece of metal in a vial.
AuroMedics Pharma is voluntarily...
10/14/2022
Pharmacy Learning Network
News
Bronchodilator Recalled
10/14/2022
Jolynn Tumolo
A Class II recall has been issued for 103,150 vials of a prescription bronchodilator following the report of a hair found in a vial.
A Class II recall has been issued for 103,150 vials of a prescription bronchodilator following the report of a hair found in a vial.
A Class II recall has been...
10/14/2022
Pharmacy Learning Network
News
Class I, II Recalls for Hand Sanitizers Distributed in Two States
10/14/2022
Jolynn Tumolo
The US Food and Drug Administration has designated hand sanitizer recalls Class I and Class II due to contamination concerns.
The US Food and Drug Administration has designated hand sanitizer recalls Class I and Class II due to contamination concerns.
The US Food and Drug...
10/14/2022
Pharmacy Learning Network
News
Investigational Oral Agent Significantly Reduces Alzheimer Disease Biomarkers
10/14/2022
Jolynn Tumolo
After 12 months of treatment with investigational oral agent ALZ-801 (valiltramiprosate), patients with early Alzheimer disease demonstrated statistically significant and clinically relevant plasma biomarker reduction.
After 12 months of treatment with investigational oral agent ALZ-801 (valiltramiprosate), patients with early Alzheimer disease demonstrated statistically significant and clinically relevant plasma biomarker reduction.
After 12 months of treatment...
10/14/2022
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use